Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

32 ta ish

Ish: Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

  1. The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis

    Dennis Falzon, Ernesto Jaramillo, Holger J. Schünemann

    Maqola20115 iqtibos
    ABI

  2. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study

    Elisabeth Sánchez-Padilla, Caroline Marquer, Stobdan Kalon +5

    Maqola20145 iqtibos
    ABI

  3. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

    Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori +11

    Sharh maqola20124 iqtibos
    ABI

  4. Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection

    Maryline Bonnet, Manuela Pardini, Francesca Meacci +14

    Maqola20114 iqtibos
    ABI

  5. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

    Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82

    Sharh maqola20144 iqtibos
    ABI

  6. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

    Ekaterina V. Kurbatova, A. Taylor, Victoria M. Gammino +13

    Maqola20123 iqtibos
    ABI

  7. Comparison of Treatment Outcomes of New Smear-Positive Pulmonary Tuberculosis Patients by HIV and Antiretroviral Status in a TB/HIV Clinic, Malawi

    Hannock Tweya, Caryl Feldacker, Sam Phiri +9

    Maqola20132 iqtibos
    ABI

  8. Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

    James C. Johnston, Neal Shahidi, Mohsen Sadatsafavi +1

    Sharh maqola20092 iqtibos
    ABI

  9. High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010

    Elisabeth Sánchez-Padilla, Themba Dlamini, Alexandra Ascorra +7

    Maqola20122 iqtibos
    ABI

  10. Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

    Vija Skripconoka, Manfred Danilovitš, Lea Pehme +10

    Maqola20122 iqtibos
    ABI

  11. Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

    Andreas H. Diacon, Peter R. Donald, Alexander S. Pym +11

    Maqola20122 iqtibos
    ABI

  12. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  13. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  14. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI